Unlock instant, AI-driven research and patent intelligence for your innovation.

Cubic liquid crystalline precursor injection of oncolytic virus and preparation method thereof

An oncolytic virus, liquid crystal precursor technology, applied in the directions of liquid delivery, medical preparations without active ingredients, and medical preparations containing active ingredients, etc. The effect of improving in vitro stability, easy availability of raw materials, and maintaining drug activity

Inactive Publication Date: 2017-04-26
GUANGZHOU ZHONGDA NANSHA TECH INNOVATION IND PARK +1
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, there are still some oncolytic virus drugs that have just entered the clinical research stage
[0005] The shortcomings of existing oncolytic virus drug preparations are mainly that the virus is easily inactivated and the solution is easy to leak

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cubic liquid crystalline precursor injection of oncolytic virus and preparation method thereof
  • Cubic liquid crystalline precursor injection of oncolytic virus and preparation method thereof
  • Cubic liquid crystalline precursor injection of oncolytic virus and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] This example provides a cubic liquid crystal precursor injection of oncolytic virus, which is prepared from the following raw materials:

[0044]

[0045] The preparation method of the cubic liquid crystal precursor injection of the oncolytic virus is as follows:

[0046] Weigh 0.500g GMO and 0.035g F127 and eutectic at 37°C to obtain mixture I; weigh 0.1ml HSV-1 and add it to 0.365ml dispersion medium, shake well to obtain mixture II (0.47g); vortex Slowly add the mixture II to the mixture I dropwise, and vortex evenly to obtain the cubic liquid crystal precursor injection of the oncolytic virus. Seal and store at -4°C.

Embodiment 2

[0048] This example provides a cubic liquid crystal precursor injection of oncolytic virus, which is prepared from the following raw materials:

[0049]

[0050]

[0051] The preparation method of the cubic liquid crystal precursor injection of the oncolytic virus is as follows:

[0052] Weigh 0.550g GMO and 0.025g F127 and eutectically melt at 37°C to obtain mixture I; weigh 0.1ml HSV-1 and add it to 0.325ml dispersion medium, shake well to obtain mixture II (0.43g); vortex Slowly add the mixture II to the mixture I dropwise, and vortex evenly to obtain the cubic liquid crystal precursor injection of the oncolytic virus. Seal and store at -4°C.

Embodiment 3

[0054] This example provides a cubic liquid crystal precursor injection of oncolytic virus, which is prepared from the following raw materials:

[0055]

[0056] The preparation method of the cubic liquid crystal precursor injection of the oncolytic virus is as follows:

[0057] Weigh 0.650g GMO and 0.015g F127 and eutectic at 37°C to obtain mixture I; weigh 0.1ml HSV-1 and add it to 0.235ml dispersion medium, shake well to obtain mixture II (0.34g); vortex Slowly add the mixture II to the mixture I dropwise, and vortex evenly to obtain the cubic liquid crystal precursor injection of the oncolytic virus. Seal and store at -4°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Viscosityaaaaaaaaaa
Titeraaaaaaaaaa
Login to View More

Abstract

The invention relates to a cubic liquid crystalline precursor injection of oncolytic virus and a preparation method thereof. The injection is mainly prepared from the following raw materials in weight percent: 45-95% of a liquid crystalline material, 0.5-10% of a phase change regulator and 4-54% of oncolytic virus nutrient solution, wherein the liquid crystalline material is monoolein, the phase change regulator is poloxamer, the oncolytic virus nutrient solution consists of oncolytic virus and a dispersion medium in a volume ratio of 1:(2-4); and the dispersion medium is a PBS buffer solution containing inositol and sorbitol, and the concentrations of inositol and sorbitol in the dispersion medium are respectively 35-45mg / mL and 15-25mg / mL. The cubic liquid crystalline precursor injection of oncolytic virus provided by the invention can improve the in-vitro stability and in-vivo safety of the virus, is low in viscosity, good in liquidity and easy to inject, can form cubic liquid crystalline gel rapidly after injection, can release virus particles slowly in situ, and cannot leak easily.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a cubic liquid crystal precursor injection of an oncolytic virus and a preparation method thereof. Background technique [0002] Melanoma is a type of malignant tumor derived from melanocytes. It is commonly found in the skin, and also in mucous membranes, eye choroid and other parts. Melanoma is the most malignant tumor type among skin tumors, and it is prone to distant metastasis. The most common treatment for melanoma is early surgical resection and mid-advanced surgical resection followed by chemotherapy and radiotherapy. [0003] At present, for the treatment of tumors, an oncolytic virus therapy has been developed, and its corresponding drug is still in the clinical research stage. The principle of oncolytic virus therapy is to selectively infect tumor cells by genetically modifying some weakly pathogenic viruses that exist in nature, using the inactivation or defect of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/768A61K9/06A61K47/10A61K47/14A61P35/00
CPCA61K47/10A61K47/14A61K9/0019A61K9/06A61K35/768
Inventor 吴传斌顾宇琨潘昕黄莹权桂兰朱春娥
Owner GUANGZHOU ZHONGDA NANSHA TECH INNOVATION IND PARK